wound model raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-06-21. Anything still debated is marked as such rather than presented as settled.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
Refers to any of the FDA procedures, such as compassionate use, parallel track, and treatment IND that distribute experimental drugs to participants who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials. (NLM) Expanded access trial
In his memoir I'm Not the Only One (2004), Galloway wrote:"Just as Stalin industrialised the Soviet Union, so on a different scale Saddam plotted Iraq's own Great Leap Forward. ... He managed to keep his country together until 1991. Indeed, he is likely to have been the leader in history who came closest to creating a truly Iraqi national identity, and he developed Iraq and the living, health, social and education standards of his own people." In the book, Galloway also expressed the opinion that Kuwait, which Iraq invaded, is "clearly a part of the greater Iraqi whole, stolen from the motherland by perfidious Albion". Christopher Hitchens responded that the state existed before Iraq had a name. The massacres of Kurds and Shias after the 1991 Gulf War, was according to Galloway, "a civil war that involved massive violence on both sides". In 2006 a video surfaced showing Galloway greeting Uday Hussein, Saddam's eldest son, with the title of "Excellency", at Uday's palace in 1999. Galloway is heard saying he will be with Uday "until the end". Galloway continued to praise Iraq's prime minister under Saddam, Tariq Aziz. In April 2005, on Al Jazeera during that year's general election campaign, he described Aziz as "an eminent diplomatic and intellectual person". In his opinion, Aziz was "a political prisoner" and advocated his release.
Nuevas Ideas retained its Legislative Assembly supermajority and, with its allies, won 43 of the country's 44 municipalities. Several news outlets described the election results as a "landslide victory" for Bukele and Nuevas Ideas, and Bukele described his victory as "the record in the entire democratic history of the world". The TSE granted Bukele his presidential credentials on 29 February and his second term began on 1 June. In a 2024 interview with Time, Bukele declined to run for a third term in the next presidential election. In July 2025, the Legislative Assembly passed several constitutional amendments, among them, the abolition of presidential term limits that made Bukele eligible to run for re-election indefinitely. Additionally, the legislature voted to move the date of the next presidential election from 2029 to 2027, reducing the length of Bukele's second term by two years. In December 2025, Bukele told YouTuber TheGrefg that "if it were up to me, I would stay for 10 more years". On 28 June 2026, Bukele registered as a pre-candidate with Nuevas Ideas, seeking a third presidential term; on 12 July, the party formally nominated him as its presidential candidate.
Sources: en.wikipedia.org
== Clinical significance == Furin is one of the proteases responsible for the proteolytic cleavage of HIV envelope polyprotein precursor gp160 to gp120 and gp41 prior to viral assembly. This protease is also thought to play a role in tumor progression. The use of alternate polyadenylation sites has been found for the FURIN gene. Furin is enriched in the Golgi apparatus, where it functions to cleave other proteins into their mature/active forms. Furin cleaves proteins just downstream of a basic amino acid target sequence (canonically, Arg-X-(Arg/Lys) -Arg'). In addition to processing cellular precursor proteins, furin is also used by a number of pathogens. For example, the envelope proteins of viruses such as HIV, influenza, dengue fever, several filoviruses including ebola and marburg virus, and the spike protein of SARS-CoV-2, must be cleaved by furin or furin-like proteases to become fully functional. When SARS-CoV-2 virus is being synthesized in an infected cell, furin or furin-like proteases cleave the spike protein into two portions (S1 and S2), which remain associated. Anthrax toxin, Pseudomonas exotoxin, and papillomaviruses must be processed by furin during their initial entry into host cells. Inhibitors of furin are under consideration as therapeutic agents for treating anthrax infection. Furin is regulated by cholesterol and substrate presentation. When cholesterol is high, furin traffics to GM1 lipid rafts. When cholesterol is low, furin traffics to the disordered region. This is speculated to contribute to cholesterol and age dependent priming of SARS-CoV.
"Assassination on City Hall": dominated by Germans, the Execution Department of Worker's and Soldier's Council proceeded to Poznań's City Hall, an armed group of Poles forces it to change four of the German delegates with Polish ones: Bohdan Hulewicz, Mieczysław Paluch, Henryk Śniegocki and Zygmunt Wiza. Poles thus gain control over the headquarters of Poznań Garrison and 5th Corps. 17 November 1918: the Commission of the NRL calls for a one-time collection of money called a "national tax". 18 November 1918: elections to Poviat's People's Councils and members of the partition's Sejm (1399 MPs). 20 November 1918: the Polish government in Warsaw publishes przyłączenie Wielkopolski będzie jednym z pierwszych naszych zadań (the joining of Greater Poland will be one of our first tasks). 3 December 1918: The Partition Sejm of Poznań begins its official proceedings in the "Apollo" Cinema. MPs represent all lands of the Prussian Partition and Polish economic emigration, mainly from Westfalen. 5 December 1918: the end of the Partition Sejm, which declared its desire for unification with the other partitions in a renewed Poland, and the NRL officially elected its members. 6 December 1918: the first meeting of the NRL has Bolesław Krysiewicz become the speaker. Election of executive body, Commission of the NRL, formed by representatives of Greater Poland - Stanisław Adamski and Władysław Seyda; Upper Silesia: Wojciech Korfanty and Józef Rymer; Eastern Pomerania: Stefan Łaszewski; Kuyavia: Adam Poszwiński.
== Safety == DNCB induces a type IV hypersensitivity reaction in almost all people exposed to it, so it is used medically to assess the T cell activity in patients. This is a useful diagnostic test for immunocompromised patients. It can also be used to treat warts. DNCB can cause contact dermatitis.
The specific matchups involving the third-place teams depended on which eight third-place teams qualified for the round of 32, but not on their relative rankings. The 495 possible combinations were published in Annex C of the tournament regulations. Because of the specific combination of qualified teams, option number 67 of annex C was applicable.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.